A recent study in colorectal cancer demonstrated that integrin α6β4 stimulates p53 phosphorylation in response to cisplatin and that integrin β4 knockdown caused resistance to platinum treatment in cells in which wildtype p53 is stabilized (61). The gene discussed is TP53; the disease is colorectal cancer.